Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|14|9|794-816

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.9, 2014-01, pp. : 794-816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Purinome, a Complex Mix of Drug and Toxicity Targets

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1117-1127

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic determinants of anti-cancer drug activity and toxicity

By Danesi R.   De Braud F.   Fogli S.   Di Paolo A.   Del Tacca M.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 8, 2001-08 ,pp. : 420-426

Elsevier

Access to resources Recommend Favorite

Effect of cisplatin and cis-platinum (II) phosphonate complex on murine mast cells

By Brzezinska-Blaszczyk E.   Mincikiewicz M.   Ochocki J.  

European Journal of Pharmacology, Vol. 298, Iss. 2, 1996-03 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite

Status of Non-Classical Mononuclear Platinum Anticancer Drug Development

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 11, 2009-10 ,pp. : 1357-1366

Bentham Science Publishers

Access to resources Recommend Favorite

Methods for Elucidation of DNA-Anticancer Drug Interactions and their Applications in the Development of New Drugs

By  

Current Pharmaceutical Design, Vol. 22, Iss. 44, 2017-01 ,pp. : 6596-6611

Bentham Science Publishers

Access to resources Recommend Favorite